"LONDON, UK â€” The European Commission (EC) has followed the recommendation last year from its Committee for Medicinal Products for Human Use (CHMP) for an additional indication for the oral platelet inhibitor ticagrelor (Brilique, AstraZe"...
Additional Neostigmine Methylsulfate Information
- Neostigmine Methylsulfate Drug Interactions Center: neostigmine methylsulfate inj
- Neostigmine Methylsulfate Side Effects Center
- Neostigmine Methylsulfate FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.